Hospices Civils de Lyon - Hôpital Edouard Herriot
Lyon, 69003, France
NCT Number: NCT01947270
Drug prescription is a fundamental component of care for the elderly. Even if drugs are a chance for the older patient, because of changes in pharmacological, pharmacokinetic and pharmacodynamic parameters related with age and acute/or chronic pathologies, the risks associated with drug prescription, particularly those associated with potentially inappropriate medication (PIM), are increased in the elderly.
We suppose that many of hospitalized elderly have at least one prescribed medication without valid indication. Conversely, many diseases are currently undertreated in elderly patients: e.g. medicines used to treat heart failure and osteoporosis are underused in 20 to 70% of patients. Moreover, PMI prescription is associated with an increased of morbidity, mortality, risk of drug-related adverse events, utilization of health care system, care costs and impairment of quality of life. Thus, optimization of drug prescription is a major concern for improvement of the quality and safety of care in elderly.
The investigators' hypothesis is that a multidisciplinary program entitled "Optimisation de la Prescription MEDicamenteuse" ("Optimization of drug prescribing") focused on drug prescription optimization including a physician training to the specificity of the drug prescription in the elderly and a checklist allowing an adapted and standardized pharmaceutical analysis is effective in reducing PIM in elderly patients hospitalized in short-term medical and geriatric care departments.
Looking for future studies?
Notify Me75 year and older
All sexes
Observational
Lyon, 69003, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The multidisciplinary intervention program include:
Time frame: at discharge (average 3 weeks)
Proportion of prescribed PIM will be expressed as the ratio of PIM to the total number of medication in discharge prescription sheet.
PIM will be identified by 2 experts (1 doctor and 1 pharmacist) based on criteria from the lists STOPP/START and Laroche.
Time frame: at discharge (average 3 weeks)
Time frame: 12 months after inclusion
Time frame: 12 months after inclusion
Time frame: 12 months after inclusion
Hospices Civils de Lyon
Other
OPMED STUDY: Multidisciplinary Program "Optimization of Drug Prescription" : Impact on the Quality of Drug Prescription in Hospitalized Elderly Patients
Acronym: OPMED
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05756478
Multimorbidity, Polypharmacy
Singapore, Sinagpore
View Trial DetailsNCT05218343
Potentially Inappropriate Medications
New York, United States
View Trial DetailsNCT05336565
Potentially Inappropriate Medications
Tomsk, Russia
View Trial DetailsNCT05875623
Aged, Deprescriptions
Subang Jaya, Selangor, Malaysia
View Trial Details